Currently, there are 478.06M common shares owned by the public and among those 411.89M shares have been available to trade.
The company’s stock has a 5-day price change of 1.97% and 15.33% over the past three months. PATH shares are trading -41.55% year to date (YTD), with the 12-month market performance down to -26.52% lower. It has a 12-month low price of $10.37 and touched a high of $27.87 over the same period. PATH has an average intraday trading volume of 8.87 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 8.39%, 12.50%, and -6.95% respectively.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Institutional ownership of UiPath Inc (NYSE: PATH) shares accounts for 49.07% of the company’s 478.06M shares outstanding.
It has a market capitalization of $8.05B and a beta (3y monthly) value of 0.94. The earnings-per-share (ttm) stands at -$0.20. Price movements for the stock have been influenced by the stock’s volatility, which stands at 3.01% over the week and 3.81% over the month.
Earnings per share for the fiscal year are expected to decrease by -24.24%, and 10.42% over the next financial year. EPS should grow at an annualized rate of 32.50% over the next five years, compared to 20.57% over the past 5-year period.
Looking at the support for the PATH, a number of firms have released research notes about the stock. Macquarie stated their Neutral rating for the stock in a research note on June 03, 2024, with the firm’s price target at $29-$12. Truist was of a view on May 30, 2024 that the stock is Hold, while TD Cowen gave the stock Hold rating on May 30, 2024, issuing a price target of $28- $17. Needham on their part issued Hold rating on May 30, 2024.
